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Adipocyte-derived cytokine resistin causes
endothelial dysfunction of porcine coronary
arteries
Panagiotis Kougias, MD, Hong Chai, MD, PhD, Peter H. Lin, MD, Alan B. Lumsden, MD,
Qizhi Yao, MD, PhD, and Changyi Chen, MD, PhD, Houston, Tex
Objective: Resistin, a novel adipocyte-derived cytokine, is involved in the development of insulin resistance and diabetes
mellitus. In this study, we determined whether resistin could affect vasomotor function, oxidative stress, and endothelial
nitric oxide synthase (eNOS) expression in porcine coronary arteries.
Methods: Porcine coronary arteries were treated with resistin or antioxidant seleno-L-methionine (SeMet). Vasomotor
function was studied by using a myograph system. Levels of superoxide anion (O2) were detected by the lucigenin-
enhanced chemiluminescence method. The eNOS mRNA and protein levels were determined by real-time polymerase
chain reaction and immunohistochemistry, respectively. Culture of isolated porcine coronary artery endothelial cells
(PCAECs) was also included.
Results: Endothelium-dependent relaxation in response to bradykinin was reduced by 15% and 30% for the rings treated
with 10 and 40 ng/mL of resistin, respectively, as compared with controls (P < .05). Endothelium-independent
relaxation in response to sodium nitroprusside (SNP) was also reduced by 11% after treatment with 40 ng/mL of resistin
(P < .05). The O2 level was increased in the 40 ng/mL resistin-treated vessels by 88% as compared with controls (P <
.05). SeMet reversed these effects. The eNOS mRNA levels in PCAEC cultures treated with resistin (10 and 40 ng/mL)
were decreased by 27% and 55%, respectively (P< .05) and by 39% in the endothelial cells purified from porcine coronary
artery rings after treatment with 40 ng/mL of resistin (P< .05). Immunoreactivity of eNOS in the resistin-treated vessel
rings was also substantially reduced.
Conclusions: Resistin reduces the endothelium-dependent and endothelium-independent vasorelaxation. This effect is
associated with increased superoxide radical production, decreased eNOS expression, and is effectively reversed by the
antioxidant SeMet. (J Vasc Surg 2005;41:691-8.)
Clinical relevance. Obesity has been considered to be an independent risk factor for coronary artery disease and other
vascular lesions. Resistin is a newly discovered adipocyte-derived cytokine, and its plasma levels are increased in obese
individuals. However, it is not clear whether resistin could directly contribute to vascular disease formation. This study
showed that resistin can cause endothelial dysfunction in porcine coronary arteries through oxidative stress and
down-regulation of eNOS. Thus, this study may suggest a new mechanism of obesity-associated vascular disease and that
antioxidants may effectively prevent vascular disease in obese individuals.Insulin-resistant metabolic syndrome affects a large
number of North Americans and is associated with in-
creased rates in cardiovascular disease that represents a
major cause of morbidity and mortality for Western societ-
ies.1 Despite divergent views regarding the exact pathogen-
esis of atherosclerosis,2,3 it is generally accepted today that
the fundamental problem that initiates and propagates the
atherosclerotic lesion is the presence of an altered state of
endothelial cell homeostasis, or endothelial dysfunction.4
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doi:10.1016/j.jvs.2004.12.046Over the past few years, much effort has been made to
comprehend the mechanisms that link insulin resistance
with endothelial dysfunction.5 Particular emphasis has been
placed on the adipocyte-derived hormones (adipokines)
that not only function prominently in the pathogenesis of
the insulin-resistant syndrome but may also serve as impor-
tant vasoactive factors, directly affecting endothelial func-
tion and vascular health.
It has been suggested that resistin, a recently described
adipokine, has a role in the development of insulin resis-
tance and obesity.6 Resistin is produced during adipogen-
esis and inhibits glucose uptake in skeletal muscle cells in
animal models.7 Although a great deal of controversy sur-
rounds its exact biologic roles in humans, recent studies
suggest that resistin promotes the development of endo-
thelial dysfunction. Verma et al8 studied the effect of resis-
tin on human saphenous vein endothelial cell activation.
They found that resistin promotes endothelial cell activa-
tion by promoting endothelin-1 (ET-1) release. Resistin
can up-regulate the vascular cell adhesion molecule
(VCAM-1), intercellular adhesion molecule-1 (ICAM-1),
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while down-regulating the expression of tumor necrosis
factor–receptor-associated factor-3 (TRAF-3), an inhibitor
of CD40 ligand signaling.8,9 In addition, resistin can in-
duce pentraxin 3, a marker of inflammation.9
In the present study, we hypothesized that the adipo-
kine resistin adversely affects endothelial function and im-
pairs vascular relaxation. To test this hypothesis we investi-
gated the effects of human recombinant resistin in a porcine
coronary artery model. Plausible mechanisms for the endo-
thelial cell dysfunction via altered endothelial nitric oxide
synthase (eNOS) levels or increased consumption of nitric
oxide (NO) by superoxide radicals were also investigated.
Our findings suggest vascular effects of the adipokine resistin
and lend credence to the concept of adipocyte-endothelial cell
interaction in states of insulin resistance and obesity.
METHODS
Chemicals and reagents. Thromboxane A2 analogue
U46619 (9,11-Dideoxy-11,9-epoxymethanoprostag-
landin F2), bradykinin, sodium nitroprusside (SNP),
phosphate-buffered saline (PBS) solution, seleno-L-methi-
onine (SeMet), and Tri-reagent kit were obtained from
Sigma Chemical (St. Louis, Mo). Human recombinant
resistin was obtained from Phoenix Pharmaceuticals, Inc
(Belmont, Calif). Lucigenin was obtained from Molecular
Probes (Eugene, Ore). Dulbecco modified Eagle’s medium
(DMEM) was obtained from Life Technologies, Inc
(Grand Island, NY). Antibiotic-antimycotic solution was
obtained from Mediatech Inc (Herndon, Va). iScript
cDNA Synthesis Kit and the iQ SYBR Green SuperMix Kit
were obtained from Bio-Rad Laboratories (Hercules,
Calif). Antibody against human eNOS was obtained from
BD Transduction Laboratories (Lexington, Ky). The bio-
tinylated horse anti-mouse immunoglobulin G (IgG) and
avidin-biotin complex kit were obtained from Vector Labs
(Burlingame, Calif).
Tissue harvest and cell culture. Fresh porcine hearts
were harvested from farm pigs (6 to 8 months old) at a local
slaughterhouse. The hearts were rinsed with sterile PBS,
the aortic arch and coronary arteries were perfused with
cold PBS, and each was stored in ice cold PBS for transport
back to the laboratory. The right coronary arteries were
carefully dissected, the perivascular loose connective tissue was
removed, and the arteries were cut into 5-mm rings. Several
rings from each heart were allocated into groups: controls
(dimethyl sulfoxide [DMSO]), those treated with resistin
(10 and 40 ng/mL), and those treated with 40 ng/mL of
resistin plus 100 M of the commonly used antioxidant
SeMet. The use of 100 M of SeMet was based on experi-
ence and previous publications that showed potent antiox-
idant effects of SeMet at this concentration.10-12 The rings
were incubated in DMEM with each drug or DMSO with
an equivalent amount in resistin solution (40 ng/mL) at
37°C and 5% CO2 for 24 hours.
Porcine coronary endothelial cells (PCAECs) and cul-
ture medium were obtained from Cell Applications, Inc
(San Diego, Calif). The cells were used at passage 6 to 7.Once the PCAECs grew to 80% to 90% confluence in
6-well culture plates, they were treated with the medium
containing DMSO as control or with resistin (10 or 40
ng/mL) for 24 hours at 37°C. Cells were then harvested,
and total mRNA was extracted for real-time polymerase
chain reaction (PCR) study.
Myograph analysis. The myograph tension system
used in our laboratory has been previously described.13-16
Briefly, the rings were cultured in the medium for 24 hours
and then were suspended between the wires of the organ
bath chamber (Multi myograph system 700MO; Myo
Technology, Aarhus N, Denmark) in 6 mL of Kreb’s solution.
After equilibration, each ring was precontracted with 20L of
thromboxane A2 analogue U46619 (107 M). After 60 to
90 minutes of contraction, the relaxation dose-response
curve was generated by adding 60 L of five cumulative
additions of the endothelium-dependent vasodilator brady-
kinin (109, 108, 107, 106, and 105 M) every 3
minutes. In addition, 60L of SNP (106 M) was added to
the organ bath, and endothelium-independent vasorelax-
ation was recorded.
Detection of O2
. Levels of O2
 produced by endo-
thelial cells were detected by using the lucigenin-enhanced
chemiluminescence method with a Sirius Luminometer
and FB12 software from Berthold Detection System
GmbH (Pforzheim, Germany) as previously described.15
Briefly, vessel rings from each of the four experimental
groups were used. The rings were cut open longitudinally
and trimmed into 5-  5-mm pieces. They were then
rinsed briefly in a modified Kreb’s HEPES buffer solution.
An assay tube (12 75 mm) was filled with 500 L buffer
and 25 L lucigenin, and after the vessel segments were
gently vortexed, they were placed endothelium-side-down
in the tubes so signals from the endothelial layer could be
recorded. Time-based reading of the luminometer was
recorded by FB12 software. The data, in relative light units
per second (RLU/s) for each sample, were averaged be-
tween 5 and 10 minutes. Final data were represented as
RLU/s/mm2.
Real-time PCR. Total RNA from cultured PCAECs
was isolated using Tri-Reagent following the manufac-
turer’s instructions. In separate experiments, porcine coro-
nary artery rings were incubated with different concentra-
tions of resistin, SeMet, or both for 24 hours, and the
endothelial cells were scraped off the vessel intima and
processed using Tri-Reagent as previously described.17,18
Briefly, the RNA from each well was resuspended in 20 L
of RNase-free water. cDNA was generated by reverse tran-
scription from mRNA using the iScript cDNA Synthesis
Kit. Next, the iQ SYBR Green SuperMix Kit was used for
real-time PCR reaction. Porcine eNOS and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) primers were
designed using Beacon Designer. The eNOS (GeneBank
#AY266137) primer sequences are: forward primer 5=-
CCCTACAACGGCTCCCCTC-3= and reversed primer
5=-GCTGTCTGTGTTACTGGATTCCTT-3=. The
GAPDH (GeneBank #AF017079) primer sequences are:
forward primer 5=-TGTACCACCAACTGCTTGGC-3=
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GAG-3=. Sample cycle threshold (Ct) values were determined
from plots of relative fluorescence units (RFU) versus PCR
cycle number during exponential amplification so that sample
measurement comparisons were possible. The eNOS gene
expression in each sample was calculated as 2^(40 – Ct) and
further normalized to GAPDH expression as [2^(Ct[GAPDH]
– Ct[eNOS])].
19,20
Immunohistochemistry of eNOS. Treated rings
were fixed in 10% neutral buffered formalin and embedded
in paraffin. Cross-sections were stained with monoclonal
antibody against human eNOS (1:1000) using avidin-
biotin complex immunoperoxidase procedure. Sections
were counterstained and viewed on an Olympus BX41
microscope (Olympus USA, Melville, NY). Images were
captured with an attached SPOT-RT digital camera and
software (Diagnostic Instruments, Sterling Heights,
Mich).
Statistical analysis. Statistic analysis was performed
on the Data Analysis tool of the Microsoft Excel program
(Microsoft Office 2000, Microsoft Inc, Seattle, Wash).
Data were expressed as mean SEM. Significant difference
of data between the control and treated groups was deter-
mined by the paired Student t test (two-tail). Comparison
of vasorelaxation in response to a series of concentrations of
bradykinin between controls and resistin-treated vessels
was analyzed with a single factor analysis of variance
(ANOVA) test. Furthermore, the final data points of all
contractions and relaxations among different groups were
also analyzed by ANOVA test. P  .05 was considered
statistically significant.
RESULTS
Resistin impairs relaxation in porcine coronary ar-
teries in a dose-dependent manner. Porcine coronary
arteries were cultured for 24 hours with a clinically relevant
concentration of 10 or 40 ng/mL of human recombinant
resistin and subsequently subjected to contraction
(U46619) and endothelium-dependent (bradykinin) and
endothelium-independent (SNP) relaxation (n  10 for
each group). In response to U46619, the contraction of the
vessel rings was increased by 4% and 13% for resistin (10 and
40 ng/mL), respectively, as compared with controls; how-
ever, this did not reach statistical significance (P 	 .05,
t test, Fig 1, A). ANOVA analysis did not show a significant
difference of contraction among groups. In response to
bradykinin at 105 M, the endothelium-dependent relax-
ation was significantly reduced by 15% for the rings treated
with 10 ng/mL of resistin and by 30% for the group treated
with 40 ng/mL of resistin as compared with controls (P
.05, ANOVA, Fig 1, B). The endothelium-independent
vasorelaxation in response to SNP was reduced by 7% in the
rings treated with 10 ng/mL of resistin and 11% for the
porcine arteries treated with 40 ng/mL of resistin as com-
pared with controls (P  .05, t test and ANOVA, Fig 1, C).
Resistin increases superoxide anion production in
porcine coronary arteries. Oxidative stress is one of the
important mechanisms of endothelial dysfunction and vas-Fig 1. Effect of resistin on the vasomotor function of porcine coro-
nary arteries. Pig right coronary arteries (n 10) were cultured with
medium-dimethyl sulfoxide (as control) or treated with resistin (10 or
40 ng/mL) for 24 hours. A, Maximal contraction of the vessel rings
in response to thromboxane A2 analogue U46619 (107 M). Con-
tractility was increased in the rings treated with resistin; however, this
did not reach statistical significance (P 	 .05, t test and analysis of
variance [ANOVA]) compared with controls. B, Precontracted ves-
sels were tested for endothelium-dependent relaxation by addition of
bradykinin (109 to 105 M). We observed a statistically significant
reduction in the resistin-treated samples compared with controls (*P
 .05, ANOVA). C, Endothelium-independent relaxation in re-
sponse to sodium nitroprusside (106 M) was significantly reduced in
the vessels treated with 40 ng/mL of resistin (*P  .05, t test and
ANOVA). Data shown are means SEM.
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volved in resistin-induced vasomotor dysfunction, O2

production was analyzed by lucigenin-enhanced chemilu-
minescence assay (n 3). The O2
 levels of the endothelial
layer of vessel rings were significantly increased by 88% for
40 ng/mL of resistin as compared with control samples (P
 .05,  t test, Fig 2). The O2
 level in the rings that were
treated with 10 ng/mL of resistin increased by 40%; how-
ever, this was not statistically significant (P 	 .05). The
addition of SeMet substantially reversed the effect of resis-
tin. Rings treated with 40 ng/mL of resistin plus SeMet
demonstrated a 25% increase in the O2
 levels as compared
with controls (P 	 .05, t test, Fig 2).
Antioxidant SeMet blocks resistin-induced vaso-
motor dysfunction in porcine coronary arteries.
Known as an antioxidant, SeMet has been shown to in-
crease the activity of glutathione peroxidase in endothelial
cells.10 To further confirm oxidative stress is involved in
resistin-induced vessel dysfunction, vessel rings cultured
with 40 ng/mL of resistin alone showed that the maximum
bradykinin (105 M)-induced relaxation was significantly
decreased; however, the addition of SeMet totally reversed
this effect and, in fact, increased vasorelaxation by 11%
compared with controls. ANOVA analysis showed a signif-
icant difference of bradykinin-induced vasorelaxation
among groups (P .05). In a similar manner, endothelium-
independent vasorelaxation after exposure to SNP was de-
creased by 11% in the rings treated with 40 ng/mL of
resistin. The addition of SeMet reversed this effect and
increased the vasorelaxation by 3% as compared with con-
trols (Fig 3, A to C).
Resistin reduces eNOS expression in porcine coro-
nary arteries. To determine whether eNOS expression
Fig 2. Effect of resistin on the O2 production in porcine coro-
nary arteries. O2
 levels in porcine coronary arteries were tested
with lucigenin-enhanced chemiluminescence assay. The data were
normalized with area (mm2) of the ring and are expressed as
relative light units (RLU/sec/mm2). Resistin (40 ng/mL) signifi-
cantly increased the O2
 levels of vessel rings (*P  .05, n  3).
The antioxidant seleno-L-methionine (SeMet) blocked the
resistin-induced O2
 production.was correlated with the reduction of endothelium-Fig 3. Effect of antioxidant seleno-L-methionine (SeMet) on the resis-
tin-induced vasomotor dysfunction of porcine coronary arteries. Vessel
rings were cultured with SeMet (100M), resistin (40 ng/mL), or both
for 24 hours (n  5). A, Maximal contraction of the vessel rings in
response to U46619 (107 M). There was no statistically significant
difference among the rings treated with resistin or SeMet, or both,
compared with controls (t test and analysis of variance [ANOVA]). B,
Endothelium-dependent vasorelaxation of the precontracted vessel rings
in response to bradykinin (109 to 105 M). Resistin significantly inhib-
ited bradykinin-induced vasorelaxation (*P  .05, ANOVA). SeMet
blocked this effect. C, Endothelium-independent vasorelaxation in re-
sponse toSNP(106 M).Resistin40ng/mLinterferedwith the sodium
nitroprusside-induced vasorelaxation (*P 0.05, t-test, and ANOVA),
and SeMet reversed this effect.
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cine coronary artery rings were incubated with resistin (10
or 40 ng/mL), SeMet, or resistin (40 ng/mL) and SeMet
simultaneously (n  6). The eNOS levels were then calcu-
lated using real-time PCR and were found to be signifi-
cantly reduced by 39% (P  .05) after treatment with 40
ng/mL of resistin as compared with controls. After co-
treatment of the rings with SeMet and 40 ng/mL of
resistin, the noted decrease in eNOS mRNA expression was
only 4% as compared with controls, indicating a complete
reversal of the resistin effect (Fig 4).
Immunohistochemistry analysis (n  3) for eNOS was
also performed in porcine coronary artery rings. Immuno-
reactivity of eNOS of the endothelial cells in resistin-treated
vessel rings was also substantially reduced (Fig 5) as com-
pared with controls.
Resistin reduces eNOS expression in PCAECs. To
determine the impact of resistin on eNOS expression,
eNOS mRNA levels were calculated using real-time PCR
in endothelial cells in culture (n 6 for each group). The
eNOS mRNA levels were significantly reduced by 27% (P
 .05, t test) and 55% (P  .05, t test) in the group, as
compared with controls treated with resistin (10 and 40
ng/mL), respectively (Fig 6).
DISCUSSION
The present study demonstrated for the first time the
direct effects of resistin on coronary artery dysfunction and
Fig 4. Effect of resistin on the endothelial nitric oxide synthase
(eNOS) mRNA level of porcine coronary arteries. Porcine coro-
nary rings were cultured for 24 hours in medium (dimethyl sulfox-
ide [control]) with resistin at concentrations of 10 and 40 ng/mL,
with seleno-L-methionine (SeMet), or with resistin (40 ng/mL)
plus SeMet. The total mRNA was purified from endothelial layers
of the rings. The eNOS mRNA expression was quantified with
real-time PCR. The eNOS mRNA level in each sample was nor-
malized to that of glyceraldehyde phosphate dehydrogenase
(GAPDH). Relative eNOS mRNA level was presented as
[2^(Ct[GAPDH]Ct[eNOS])]. Treatment with resistin (40 ng/mL)
significantly decreased the eNOS mRNA expression compared
with controls (*P .05, n 6, t test). This effect was reversed with
the addition of SeMet.the association with eNOS expression and O2
 production.Using the model of porcine coronary artery rings, we have
shown that resistin has a detrimental effect that results in
vasomotor dysfunction, eNOS down-regulation, and O2

over production. Furthermore, antioxidant therapy could
completely block these adverse effects of resistin.
Resistin is a member of a newly discovered family of
cysteine-rich secretory proteins called resistin-like molecules
(RELM) or found in the inflammatory zone (FIZZ). It was
initially discovered in a screen to identify potential targets
of the thiazolidinedione (TZD) class of insulin sensitizers
in 3T3-L1 adipocytes.6 Resistin is encoded by the Retn
gene and secreted as a disulfide-linked dimer.21 In mice, the
Retn gene is expressed almost exclusively in white adipose
tissue, and the protein is detectable in adipocytes and in the
blood. Unlike murine resistin, human resistin is expressed
at low levels in adipocytes but is readily detectable in
mononuclear blood cells.22,23
The pharmacokinetic properties of resistin have been
assessed. The mean plasma resistin levels in volunteers have
been reported to be from 4 to 13 ng/mL, depending on
the assay used,24,25 whereas the peak levels may be as high
as 38.35 ng/mL.26 The doses of 10 and 40 ng/mL that we
selected simulate these clinical situations. Although plasma
levels in porcine are not known this model may still be
relevant to human obesity. Both human and porcine resis-
tin genes have been cloned and share over 90% homology
of protein sequences. Our data showed human recombi-
nant resistin have cross reactions for porcine coronary ar-
teries and endothelial cells. Since resistin is a newly discov-
ered adipokine, its potential receptors are not clear yet.
Impaired vasorelaxation in response to pharmacologic
agents has been used as an indicator of vascular dysfunc-
tion. In the present study, resistin significantly im-
paired endothelium-dependent vasorelaxation in a dose-
dependent manner. For the arteries incubated with 10 and
40 ng/mL of resistin, the decrease in bradykinin-induced
vasorelaxation as compared with controls was 15% and 30%,
respectively, indicating resistin-induced endothelial cell
dysfunction. Impaired relaxation to a lesser extent took
place in the presence of SNP; resistin at 10 and 40 ng/mL
caused a decrease in the endothelium-independent vasore-
laxation by 7% and 11%, respectively, indicating a reduced
efficiency of NO released from SNP.
Endothelium produces molecular oxygen during aero-
bic respiration and generates a substantial amount of O2
.
Imbalance in the production and regulation of oxygen
radicals is known to lead to oxidative stress and contribute
to vascular disease.27 NO reacts with O2
 to form per-
oxynitrite anion (ONOO), which subsequently decom-
poses to form the highly reactive hydroxyl radical (OH).
This interaction occurs faster than the rate of O2
 produc-
tion with superoxide dismutase, thus a portion of NO can
constantly be utilized to react with O2
 and become un-
available for its biologic functions, including vasorelax-
ation.28 Evidence from cell culture and animal studies
suggests that overproduction of O2
 and subsequent oxi-
dative inactivation of NO may both be important in the
pathogenesis of atherosclerosis.28
cells.
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 production was
shown in the resistin-treated samples as compared with
controls. Furthermore, when rings were co-cultured with
resistin and antioxidant SeMet, endothelium-dependant as
well as endothelium-independent vasorelaxation returned
to levels similar to those seen in control vessels, which were
correlated with a decrease in the O2
 levels. This finding
indicates that oxidative stress may be the major mechanism
in resistin-induced vascular dysfunction. In a future study,
we will examine nitrotyrosine production in resistin-treated
vessels.
The detailed mechanisms of resistin’s action and
sources of O2
 were not determined in the current study.
O2
 could be generated from NADPH oxidase, xanthine
oxidase-uncoupled eNOS, and the mitochondria.29,30
Once produced, free radicals could be removed by antiox-
idant defenses including enzyme catalase, glutathione per-
oxidase, and superoxide dismutase.29,30 Identification of
the potential sources and characteristics of free radicals, as
well as antioxidant enzymes in resistin-treated cells warrants
further investigations.
A key process in the early pathogenesis of atherosclero-
Fig 5. Effect of resistin on the endothelial nitric oxide sy
Avidin-biotin complex immunoperoxidase procedure w
resistin-treated vessels. A, Control. B, SeMet (seleno-L
Resistin (10 ng/mL) plus SeMet. E, Resistin (40 ng/mL
ng/mL) treatment substantially reduced eNOS immuno
reversed this effect (n  3). Arrows indicate endothelialsis is diminished bioavailability of the endothelium-derivedsignaling molecule NO, which is generated by eNOS and is
a potent vasodilator with multiple additional cardiovascular
functions.31 Many lines of evidence indicate that eNOS has
a very important role in cardiovascular disease.32,33 Higher
rates of myocardial ischemia or infarction have been re-
ported in patients with polymorphisms of eNOS that re-
duce the enzyme activity.34 From our findings we believe
that the changes in endothelium-dependent relaxation may
also be due to the decrease in eNOS expression. Indeed, the
real-time PCR data showed a 55% decrease of eNOS
mRNA expression in resistin-treated vessel rings.
Effects of resistin on endothelial integrity and eNOS
protein levels were studied by immunohistochemical stain-
ing. Resistin substantially decreased eNOS immunoreactiv-
ity, whereas the change of endothelial integrity was very
minimal. However, these data could not be quantified for
statistical analysis because of the insensitivity of the inten-
sity measurement and small sample size. In future studies,
Western blot analysis could be used to semi-quantitatively
measure eNOS protein levels. Scanning or transmission
electromicroscopy would help to confirm the integrity of
e (eNOS) immunoreactivity of porcine coronary arteries.
ed to detect eNOS protein levels in both control and
hionine) alone (control). C, Resistin (10 ng/mL). D,
Resistin (40 ng/mL) plus SeMet. High dose resistin (40
ivity compared with controls, but the antioxidant SeMetnthas
as us
-met
). F,
reactendothelial cells and is warranted for future investigation.
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endothelial cells could also be included in a future study.
In recent years, we have developed and characterized
the porcine coronary artery culture model, which repre-
sents a useful tool for the study of vascular biologic and
endothelial functions.10-13 Porcine right coronary arteries
were exclusively used in this study because these vessels are
relatively superficial and have a uniform diameter 	5 cm
with fewer branches. Optimal pretension for porcine coro-
nary artery rings was determined by performing serial ex-
periments with a wide range of pre-tension. The 30 mN
pre-tension gave rise to the maximal tension change in
response to a given dose of U46619. The variability was
within a minimal range. Thus, pre-tension of 30 mN was
used for all porcine coronary artery rings for myograph
analysis.
In addition, porcine coronary arteries were harvested
from a local slaughterhouse, stored in 4°C PBS, and trans-
ferred into the lab for experiments. In our experience, the
vessel rings do not respond well in acute study because of
cold ischemia. The vessels cultured for 24 hours at 37°C
show the optimal response; thus, we did not perform an
acute study because the data might not have been reliable.
Prostaglandins are thought to be involved in the vascu-
lar system through both vasoconstrictor and vasodilator
actions. Endoperoxides are converted to the vasoconstric-
tor thromboxane through the cyclo-oxygenase pathway,
which may also generate the vasodilators, prostacyclin and
prostaglandin E-2.35 The effect of resistin on prostaglandin
activity is not known and should be interesting to investi-
gate.
Our findings are consistent with those from the above-
Fig 6. Effect of resistin on the endothelial nitric oxide synthase
(eNOS) mRNA levels of porcine coronary artery endothelial cells
in culture. The cells were incubated with resistin (10 or 40 ng/mL)
for 24 hours. Real-time polymerase chain reaction was used to
assess eNOS mRNA expression. The eNOS mRNA level in each
sample was normalized to that of glyceraldehyde-s-phosphate de-
hydrogenase (GAPDH). Relative eNOS mRNA level was pre-
sented as 2^[Ct(GAPDH) – Ct(eNOS)]. Addition of resistin (10 or 40
ng/mL) substantially decreased the eNOS mRNA expression (* P
 0.05, n  6, t test). Data shown are means  SEM.mentioned studies and indicate that resistin activates endo-thelial cells and therefore may promote the initiation or
perpetuation of the atherosclerotic state. Further questions
remain unanswered, however. For instance, interspecies
variation could limit the usefulness of the observations in
animal models. It is still unclear whether there is a signifi-
cant difference in the serum resistin levels between healthy
and obese or diabetic individuals.25,26,36 The exact mech-
anism of action remains unknown at the cellular and the
molecular level. It is likely that resistin activates a receptor
on endothelial cells. However, further studies are needed to
clarify this interaction.
In summary, we have demonstrated that resistin can
cause vasomotor dysfunction, decrease eNOS expression,
and increase O2
 production in porcine coronary arteries.
Antioxidant SeMet can successfully block these resistin-
induced effects, indicating a possible molecular mechanism
and a potential therapeutic strategy in patients who are at
high risk for vascular disease. Thus, these data are of clinical
significance although in vivo experiments may be war-
ranted.
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